Wang Ping, Ren Rong-Na, Cai Shu-Ying, Chen Xin-Min, Ye Li-Yan
Department of Pediatrics, Fuzhou General Hospital of Nanjing Military Command, Fuzhou 350025, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2008 Feb;10(1):65-9.
To study the neuroprotective effects of topiramate (TPM) alone or together with folic acid (FA) on young rats with kindling-induced epilepsy.
Rat models of epilepsy were prepared by pentylenetetrazol (PTZ)-induced kindling. Seventy-two 3-week-old male Wistar rats were randomly divided into 6 groups: four TPM-treated epilepsy groups (TPM 20, 40 or 80 mg/kg/d and TPM 40 mg/kg/d + FA 5 mg/kg/d), a positive control group (untreated epilepsy group) and a negative control group (normal control group). After two months of administration, behaviors of the rats were recorded; serum levels of neuron-specific enolase (NSE) were measured using ELISA; pathological changes in the hippocampus were observed.
The frequency of convulsion seizures in the 20, 40 and 80 mg TPM treatment and TPM+FA groups was 44.7 +/- 2.9, 44.3 +/- 3.1, 42.7 +/- 3.2, and 40.8 +/- 3.7 respectively, which were significantly lower than that in the positive control group (48.4 +/- 3.7) (P <0.01). Twenty, forty and eighty mg TPM treatment and TPM+FA treatment significantly reduced NSE levels from 35.71 +/- 5.97 microg/L of the control group to 27.40+/- 6.40, 24.79 +/- 6.22, 21.47 +/- 6.87 and 22.55 +/- 7.02 microg/L respectively (P <0.05). Neuronal apoptosis in the CA3 and CA1 regions were alleviated in the four TPM treatment groups compared with positive control. The number of necrotic neurons was progressively reduced with the increased dose of TPM. The 40 mg TPM+FA treatment group showed less necrotic neurons in the CA3 and CA1 regions than the 40 mg TPM alone treatment group.
TPM has protective effects against epilepsy-induced neuronal damage. The effect is dose-dependent. A combination of TPM and FA can produce a synergistic effect.
研究托吡酯(TPM)单独或联合叶酸(FA)对戊四氮(PTZ)点燃诱导的幼年癫痫大鼠的神经保护作用。
采用戊四氮诱导点燃制备癫痫大鼠模型。将72只3周龄雄性Wistar大鼠随机分为6组:4个TPM治疗癫痫组(TPM 20、40或80mg/kg/d以及TPM 40mg/kg/d + FA 5mg/kg/d)、1个阳性对照组(未治疗癫痫组)和1个阴性对照组(正常对照组)。给药两个月后,记录大鼠行为;采用酶联免疫吸附测定法(ELISA)检测血清神经元特异性烯醇化酶(NSE)水平;观察海马区病理变化。
20mg、40mg和80mg TPM治疗组以及TPM + FA组惊厥发作频率分别为44.7±2.9、44.3±3.1、42.7±3.2和40.8±3.7,显著低于阳性对照组(48.4±3.7)(P<0.01)。20mg、40mg和80mg TPM治疗组以及TPM + FA治疗组使NSE水平从对照组的35.71±5.97μg/L分别显著降低至27.40±6.40、24.79±6.22、21.47±6.87和22.55±7.02μg/L(P<0.05)。与阳性对照组相比,4个TPM治疗组海马CA3区和CA1区神经元凋亡减轻。坏死神经元数量随TPM剂量增加而逐渐减少。40mg TPM + FA治疗组CA3区和CA1区坏死神经元数量少于40mg TPM单独治疗组。
TPM对癫痫诱导的神经元损伤具有保护作用。该作用呈剂量依赖性。TPM与FA联合可产生协同效应。